Cognitive Product
CognI·Q |
 |
INM-176
200mg
60 capsules
$45.00
|
| |
|
|
|
CognI-Q – Product Description
CognI•Q™ INM®-176 is a dietary supplement for improved overall health.* The active ingredient is INM®-176 which is derived from natural angelica root. INM-176 is show in scientific research to support healthy brain function.* CognI•Q supports and promotes normal brain function including cognitive agility, mood and emotional well being, and antioxidation.*
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
CognI•Q™ INM®-176 Fact Sheet
| - |
CognI•Q™ INM®-176 is a dietary supplement for improved overall health. |
| - |
The active ingredient is INM®-176 which is derived from natural angelica root. |
| - |
INM-176 is show in scientific research to support healthy brain function. |
| - |
CognI•Q supports and promotes normal brain function including cognitive agility, mood and emotional well being, and antioxidation. |
Overview of Cogni-QTM (INM®176)
- |
Patented proprietary extract of ingredient derived from the root of angelica gigas nakai, grown and harvested under strictly controlled conditions to yield a high content of the active ingredients - decursin and decursinol |
- |
Subject of significant research, including safety and efficacy studies on both humans and animals with studies published in several prestigious scientific journals
• INM-176 is backed by a human double-blind placebo-controlled 3-month clinical trial with 80 subjects having mild & moderate cognitive impairment at Samsung Seoul Hospital demonstrated efficacy and safety
* After 12 weeks of administration, the ADAS-cog error rate in the active group declined significantly (-4.82 points)
* This result is superior to the ADAS-cog error reduction rate in trials on the mainline pharma products including Exelon (-3.2), Remynil (-2.5), Phenserine (-1.9) and Aricept (-2.25)
• Nearing completion a Phase-III 170-patient multi-center double-placebo-controlled clinical study with very strong early results |
- |
100% natural ingredient with long history of use in traditional medicine with a strong safety profile |
- |
Having received regulatory approval, products containing the ingredient are currently being sold in Korea and Japan with excellent results for patients, driving repeat orders and attracting new customers |
|
-
|
Proposed mechanisms of action of INM-176:
• Inhibition of Amyloid β-peptide oligomer (senile plaque) formation
• Anti-oxidation
• Inhibition of inflammation
• Neuroprotection
• Inhibition of acetylcholine decline |
| Summary |
- |
Highly efficacious nutraceutical with strong safety data for age-related cognitive impairment |
|
-
|
Supported by clinical research based on pharmaceutical standards shows significant efficacy |
- |
Potential benefits include: |
| |
- Helping prevent onset of age-related memory impairment
- Promoting cognitive function
- Protecting against nerve cell death
- Helping prevent lipid peroxide production |
|
-
|
Excellent nutritional supplement ingredient for seniors concerned with memory loss and younger consumers seeking to improve mental performance |
|
